Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Subcutaneous microdialysis in mitochondrial cytopathy.

M S Damian1, W Sauter, H Reichmann

  • 1Department of Neurology, Technical University of Dresden, Fetscherstrasse 74, Dresden 01307, Germany. damian@rcs.urz.tu-dresden.de

Muscle & Nerve
|April 24, 2001
PubMed
Summary

Subcutaneous microdialysis, a minimally invasive technique, effectively monitors metabolic changes in mitochondrial cytopathy patients. This method reveals disease-specific lactate and pyruvate fluctuations, aiding in risk identification and treatment assessment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased risk of acute stroke among patients with severe COVID-19: a multicenter study and meta-analysis.

European journal of neurology·2020
Same author

[Dystonia Non-Motor Symptoms Questionnaire (DNMSQuest) for assessment of non-motor symptoms in dystonia : Intercultural adaptation in the German language].

Der Nervenarzt·2020
Same author

MMW Fortschritte der Medizin·2019
Same author

Admission patterns and survival from status epilepticus in critical care in the UK: an analysis of the Intensive Care National Audit and Research Centre Case Mix Programme database.

European journal of neurology·2019
Same author

Perfusion computed tomography in posterior circulation stroke: predictors and prognostic implications of focal hypoperfusion.

European journal of neurology·2018
Same author

Rasagiline improves polysomnographic sleep parameters in patients with Parkinson's disease: a double-blind, baseline-controlled trial.

European journal of neurology·2018

Area of Science:

  • Biochemistry
  • Neurology
  • Metabolic Disorders

Background:

  • Mitochondrial cytopathies are complex genetic disorders affecting cellular energy production.
  • Accurate biochemical monitoring is crucial for understanding disease progression and metabolic stress in these patients.
  • Current monitoring methods may lack the continuous, real-time data needed for comprehensive assessment.

Purpose of the Study:

  • To evaluate the feasibility and utility of subcutaneous microdialysis for continuous metabolic monitoring in mitochondrial cytopathy.
  • To compare metabolic profiles (lactate, pyruvate, lactate:pyruvate ratio) between patients and healthy controls.
  • To correlate microdialysis findings with disease severity and metabolic stress.

Main Methods:

  • Subcutaneous microdialysis probes were used for continuous sampling in 6 ambulatory mitochondrial cytopathy patients and 6 controls.

Related Experiment Videos

  • Lactate, pyruvate, and glucose levels were measured at regular intervals (day and night).
  • The lactate:pyruvate ratio (LPR) was calculated and analyzed in relation to disease status.

    • Main Results:

    • Microdialysis was well-tolerated by all participants.
    • Patients exhibited significantly higher and more variable lactate and pyruvate levels, with a higher average LPR compared to controls.
    • Marked diurnal variations in metabolic markers were observed, particularly in severely affected patients, with LPR increases correlating with metabolic stress.

    Conclusions:

    • Subcutaneous microdialysis is a safe and effective method for continuous metabolic monitoring in mitochondrial cytopathy.
    • The technique provides valuable insights into disease-specific metabolic dysregulation and diurnal variations.
    • Microdialysis shows potential for identifying metabolic risk factors and evaluating therapeutic interventions in mitochondrial disorders.